The Circulatory Actions of the Neurohypophysial Hormones and Similar Polypeptides

  • K. Saameli
Part of the Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology book series (HEP, volume 23)


This chapter deals with the effects of neurohypophysial and some related pep-tides on the cardiovascular system in different mammalian species. No attempt is made to elucidate the reversed relationship, namely the action of cardiovascular changes on the production and/or the release of the hormones (for this subject see chapter by M. Ginsbubg). According to the editor’s suggestion this article is confined to the recent literature and does not include older papers, unless they are of more than merely historical interest. It is hoped, however, that most of the relevant papers published later than 1947 are reviewed.


Cardiac Output Circulatory Action Pulmonary Wedge Pressure Uterine Blood Flow Systemic Arterial Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahlquist, R. P., and R.A. Woodbury: The cutaneous vasodilating action of pitressin. Fed. Proc. 4, No. 1 (1945).Google Scholar
  2. —: Influence of drugs and uterine activity upon uterine blood flow. Fed. Proc. 6, 305 (1947).PubMedGoogle Scholar
  3. Altura, B.M.: Differential actions of polypeptides and other drugs on coronary inflow vessels. Amer. Heart J. 72, 709 (1966).PubMedGoogle Scholar
  4. —, and S.G. Hershey: Effects of vasoactive drug therapy on microvascular injury in shock. Pharmacologist 7, 144 (1965).Google Scholar
  5. —, and V. D. B. Mazzia: Microcirculatory approach to vasopressor therapy in intestinal ischémic (SMA) shock. Amer. J. Surg. 111, 186 (1966).PubMedGoogle Scholar
  6. —, and B.W. Zweifach: Effects of a synthetic analogue of vasopressin on vascular smooth muscle. Proc. Soc. exp. Biol. (N.Y.) 119, 258 (1965).Google Scholar
  7. Andersen, T.W., C.B. De Padua, and V. Stenger: Cardiovascular effects of rapid intravenous injection of synthetic oxytocin during elective section. Clin. Pharmacol. Ther. 6, 345 (1965).Google Scholar
  8. Anrep, G.U., and R.S. Stacey: Comparative effects of various drugs upon coronary circulation. J. Physiol. (Lond.) 64, 187 (1927).Google Scholar
  9. Assali, N. S., L. Horm, and H. Parker: Regional blood flow and vascular resistance in response to oxytocin in the pregnant sheep and dog. J. appl. Physiol. 16, 1087 (1961).PubMedGoogle Scholar
  10. Baber, J.J., M. Chafizadeh, E.J. Halligan, and C.M. Leevy: Hemodynamic effects of posterior pituitrin in cirrhosis. Surg. Forum 11, 354 (1960); Clin. Congr. Chicago, 1960.PubMedGoogle Scholar
  11. Baisset, A., M. Carton, J. Cotonat, et P. Montastruc: Recherche d’un antagonisme entre l’histamine et la fibre lisse vasculaire et bronchique. Thérapie 20, 41 (1965).Google Scholar
  12. Barcroft, H., and A. F. Cobbold: On the action of intravenous pitressin on forearm blood flow and blood lactate in man. J. Physiol. (Lond.) 132, 10 P (1956).Google Scholar
  13. Barer, G. R.: A comparison of the circulatory effects of angiotensin, vasopressin and adrenaline in the anaesthetised cat. J. Physiol. (Lond.) 156, 49 (1961).Google Scholar
  14. —: The action of vasopressin, a vasopressin analogue (PLV2), oxytocin, angiotensin, brady-kinin and theophylline ethylene diamine on renal blood flow in the anaesthetised cat. J. Physiol. (Lond.) 169, 62 (1963).Google Scholar
  15. Bartelstone, H.J., and P.A. Nasmyth: Vasopressin potentiation of catecholamine action in dog, rat, cat, and rat aortic strip. Amer. J. Physiol. 208, 754 (1965).PubMedGoogle Scholar
  16. Bearn, A.G., B. Billing, O.G. Edholm, and S. Sherlock: Hepatic blood flow and carbohydrate changes in man during fainting. J. Physiol. (Lond.) 115, 442 (1951).Google Scholar
  17. Belinkoff, ST.: Cyclopropane-pituitrin incompatibility. Amer. J. Obstet. Gynec. 48, 109 (1944).Google Scholar
  18. Berde, B.: Some observations on the circulatory effects of oxytocin, vasopressin and similar polypeptides. In: Advances in oxytocin, p. 11. Oxford: Pergamon Press 1965.Google Scholar
  19. —, and R.A. Boissonnas: Synthetic analogues and homologues of the posterior pituitary hormones. In: The pituitary gland, p. 624. Ed. by G.W. Harris and B.T. Donovan. London: Butterworths & Co. Ltd. 1966.Google Scholar
  20. —, H. Weidmann u. A. Cerletti: Über Phenylalanin2-Lysin-Vasopressin. Helv. physiol. pharmacol. Acta 19, 285 (19PubMedGoogle Scholar
  21. Bergquist, J.R., and I.H. Kaiser: Cardiovascular effects of intravenous Syntocinon. Obstet, gynec. Surv. 13, 360 (1959).Google Scholar
  22. Betz, E., W. Niesel, F.W. Schmahl u. K. Schmidt: Lokale Durchblutung und capilläre Sauerstoffsättigung des Myokards unter Hypoxie und Hyperkapnie sowie nach Einwirkung von Adrenalin, Noradrenalin und Vasopressin. Pflügers Arch. ges. Physiol. 285, 55 (1965).Google Scholar
  23. Bieniarz J.: In: Oxytocin p. 80. Ed. by R. Caldeyro-Barcia and H. Heller. Oxford: Pergamon Press 1961.Google Scholar
  24. Bisset G.W. and G.P. Lewis: A spectrum of pharmacological activity in some biologically active peptides. Brit. J. Pharmacol. 19, 168 (1962).PubMedGoogle Scholar
  25. Black, J. W.: Electrocardiographs changes produced in rabbits by vasopressin (pitressin) and their alteration by prolonged treatment with a commercial heart extract. J. Pharm. Pharmacol. 12, 87 (1960).PubMedGoogle Scholar
  26. Brodeur, J.: Etude des propriétés antiarythmiques de quelques polypeptides hormonaux (Thèse, 1962).Google Scholar
  27. —: Effets de la Iysyl8-vasopressine synthétique sur les arythmies adrénalino-chloroformiques chez le chien anesthésié. Rev. canad. Biol. 23, 37 (1964).Google Scholar
  28. —, et A. Beaulnes: Effets de l’ocytocin sur les arythmies digitaliques chez le chien. Rev. canad. Biol. 22, 275 (1963).Google Scholar
  29. Brotánek, V., and S. Kazda: Differences in the vasodepressor reaction to oxytocin in men and nonpregnant and pregnant women. Amer. J. Obstet. Gynec. 93, 547 (1965).PubMedGoogle Scholar
  30. — —, and Č. Jungmannova: Differences in the vascular reaction to oxytocin in man and their causes. Biochem. Pharmacol. 12, Suppl., 256 (1963).Google Scholar
  31. BÜlbring, E., J.H. Burn, and J.M. Walker: Reduction in coronary flow by pituitary (posterior lobe) extract in relation to the action of nicotine and to smoking. Quart. J. Med. 18, 73 (1949).PubMedGoogle Scholar
  32. Bunac, R.D., I.H. Page, and J. W. McCubbin: Inhibition of renin release by vasopressin and angiotensin. Cardiovasc. Res. 1, 67 (1967).Google Scholar
  33. Burch, G.E., and N.P. De Pasquale: Response of the superficial lymphatics of man to phenylalanine2-lysine8-vasopressin (PLV2). Circulation 28, 697 (1963).Google Scholar
  34. —: Response of the superficial lymphatics of the arm of intact man to synthetic vasopressin. Proc. Soc. exp. Biol. (N.Y.) 117, 141 (1964).Google Scholar
  35. Burnhill, M.S., J.A. Gaines, and A.F. Guttmacher: Concentrated oxytocin solution for therapeutic interruption of midtrimester pregnancy. Obstet, gynec. surv. 20, 94 (1962).Google Scholar
  36. Byrom, F.M., and O.E. Pratt: Oxytocin and renal cortical necrosis. Lancet 1959 I, 753.Google Scholar
  37. Caldeyro-Barcia, R.: Oxytocin in pregnancy and labour. Acta endocr. (Kbh.) 34, 41, Suppl. 50 (1960).Google Scholar
  38. Caldeyro-Barcia, R. —, H. Alvarez, J.J. Poseiro, C.H. Hendricks, Y. Sica-Blanco, S.V. Pose, L.A. Cebils, M.A. Carballo, V. Gonzalez-Panizza, C. Fielitz, C. Mendez-Bauer, y E.A. De Telias: La induccion del parto con ocitocina sintética (Syntocinon). 2° Congreso Uruguayo de Ginecotocologia, October 1957.Google Scholar
  39. —, and J.J. Poseiro: Fetal and maternal dangers due to misuse of oxytocin. Extrait du Deuxième Congrès International de Gynécologie et d’Obstétrique de Montréal, en 1958, Tome II, page 450.Google Scholar
  40. Carlier, J., G. Lejeune-Ledant, et G. Barac: Effets hémodynamiques comparés d’une vaso-pressine synthétique et de la pitressine chez le chien. Arch. int. Pharmacodyn. 125, 287 (1960).PubMedGoogle Scholar
  41. Carter, A.M., P. J. Lewis, and L.P. Bengtsson: Effects of vasopressin on uterine blood flow in the rabbit. Acta pharmacol. (Kbh.) 24, 435 (1966).Google Scholar
  42. Carter, E.R., and G.P. Shaw: Cardiovascular effects of common intravenous oxytocics. Obstet, gynec. Surv. 16, 47 (1960).Google Scholar
  43. Cerletti, A., H. Weber u. H. Weidmann: Zur Wirkung von Phenylalanin2-Lysine-Vaso-pressin (Octapressin) auf den arteriellen und venösen Anteil eines peripheren Gefäßgebietes. Helv. physiol. pharmacol. Acta 21, 394 (1963).PubMedGoogle Scholar
  44. Chaudhury, U.R., and T.K. Tarak: Action of the neurohypophysial hormones on the vascular system of the male monkey and the rooster. J. Pharm. Pharmacol. 17, 316 (1965).PubMedGoogle Scholar
  45. Chenoweth, M.B., G.L. Ellman, R.C. Reynolds, and P. J. Shea: A secondary response to pressor stimuli caused by sensitization to an endogenous pituitary hormone. Circulat. Res. 6, 334 (1958).PubMedGoogle Scholar
  46. Coon, J.M.: A new method for the assay of posterior pituitary extracts. Arch. int. Pharmacodyn. 62, 79 (1939).Google Scholar
  47. Covino, B.G.: Cardiac effects of synthetic oxytocin (Syntocinon). Amer. Heart J. 66, 627 (1963).PubMedGoogle Scholar
  48. Cutchin Jr., J.H., H.S. McGattghey Jr., W.A. Scoggin, G.M. Harbert Jr., and N.W. Thornton Jr.: Contractility of the isolated human uterine artery. Amer. J. Obstet. Gynec. 90, 143 (1964).PubMedGoogle Scholar
  49. Davis Jr., W.D., R. Gorlin, S. Reichman, and J.P. Storaasli: Effect of pituitrin in reducing portal pressure in the human being. New Engl. J. Med. 256, 108 (1957).PubMedGoogle Scholar
  50. Deis, R.P., A.H. Kitchin, and M. Pickford: The effect of oxytocin on hand blood flow in man following total and sympathetic nerve block. J. Physiol. (Lond.) 166, 489 (1963).Google Scholar
  51. Diana, J.N., and R.R. Masden: Effect of vasopressin infusion and sciatic nerve stimulation in isolated dog hindlimb. J. Physiol. (Lond.) 209, 390 (1965).Google Scholar
  52. Dillon, T.F., B.E. Marbury, R.W. Bonsnes, R.G. Douglas, and V. Du Vigneaud: Vasopressin as a hemostatic in gynecologic surgery. Obstet, and Gynec. 11, 363 (1958).Google Scholar
  53. Dodd, W.A., and E.E. Daniel: Vascular muscle reactivity. Circulat. Res. 8, 446 (1960).Google Scholar
  54. Drapanas, T., C.P. Crowe, W.K.T. Shim, and W.G. Schenk Jr.: The effect of pitressin on cardiac output and coronary, hepatic, and intestinal blood flow. Surg. Gynec. Obstet. 113, 484 (1961).PubMedGoogle Scholar
  55. Dyke, H.B. Van, K. Adamsons Jr., and S.L. Engel: Aspects of the biochemistry and physiology of the neurohypophysial hormones. Recent Progr. Hormone Res. 9, 1 (1955).Google Scholar
  56. —, S. L. Engel, and K. Adamsons Jr.: Comparison of pharmacological effects of lysine and arginine vasopressins. Proc. Soc. exp. Biol. (N.Y.) 91, 484 (1956).Google Scholar
  57. Edmunds, R., and J. P. West: A study of the effect of vasopressin on portal and systemic blood pressure. Surg. Gynec. Obstet. 114, 458 (1962).PubMedGoogle Scholar
  58. Emerson Jr., T.E.: Effects of angiotensin, epinephrine, nor-epinephrine, and vasopressin on venous return. Amer. J. Physiol. 210, 933 (1966).PubMedGoogle Scholar
  59. Engstrom, L.: Induction of labour around full term, especially by means of synthetic oxytocin intravenous drip. Acta obstet, gynec. scand. 38, Suppl. 3 (1959).Google Scholar
  60. Essex, H.E., R.G.E. Wegria, J.F. Herrick, and F.C. Mann: The effect of certain drugs on the coronary blood flow of the trained dog. Amer. Heart J. 19, 554 (1940).Google Scholar
  61. Feldman, S.A., D.M. Forgaard, and L.E. Morris: Compatibility of a synthetic oxytocin (Syntocinon) with anesthesia in dogs. Anesthesiology 19, 878 (1958).Google Scholar
  62. Ferrari, G., and A. Vandone: Octapressin als lokaler Vasoconstrictor in Geburtshilfe und Gynaekologie. Minerva ginec. 16, 629 (1964) (in Italian).PubMedGoogle Scholar
  63. Fisher, S.J., J. Gehrig, and H. Green: Non-catechol amine vasopressor (PLV2) for use as adjunct to local anesthesia. J. Amer. dent. Ass. 70, 1189 (1965).PubMedGoogle Scholar
  64. Frieden, J., and A.D. Keller: Decreased resistance to hemorrhage in neurohypophysecto-mized dogs. Circulat. Res. 2, 214 (1954).PubMedGoogle Scholar
  65. Friedman, S.M., R.M. Butt, and C.L. Friedman: Cation shifts and blood pressure regulation in the dog. Amer. J. Physiol. 190, 507 (1957b).PubMedGoogle Scholar
  66. —, C. L. Friedman, and M. Nakashima: Cationic shifts and blood pressure regulation. Circulat. Res. 5, 261 (1957a).PubMedGoogle Scholar
  67. —, J. D. Jamieson, and C. L. Friedman: Sodium gradient, smooth muscle tone, and blood pressure regulation. Circulat. Res. 7, 44 (1959).PubMedGoogle Scholar
  68. —, and H. Pauls: The effect of pitressin infusion on blood pressure of the rabbit, cat and rat. Amer. Heart J. 44, 131 (1952).PubMedGoogle Scholar
  69. Green, H.D., R. Wegira, and N.H. Boyer: Effects of epinephrine and pitressin on the coronary artery inflow in anesthetized dogs. J. Pharm. Pharmacol. 76, 378 (1942).Google Scholar
  70. Gromotka, R., u. L. Demling: Der Einfluß von Vasopressin auf die Darmdurchblutung des Menschen. Klin. Wschr. 40, 456 (1962).PubMedGoogle Scholar
  71. Gruber, C.M., and W.B. Kountz: The electrocardiogram of non-anesthetized dogs as modified by the intravenous injection of pitressin, atropine sulphate and vagus section. J. Pharmacol, exp. Ther. 40, 253 (1930).Google Scholar
  72. Guhl, U.: Die antidiuretische und pressorische Wirksamkeit von Arginin8-Vasopressin, Lysin8-Vasopressin und Phenylalanin2-lysin8-Vasopressin beim Menschen. Schweiz, med. Wschr. 91, 798 (1961).Google Scholar
  73. Haddy, F. J., J.I. Molnar, and R. W. Campbell: Effects of denervation and vasoactive agents on vascular pressures and weight of dog forelimb. Amer. J. Physiol. 201, 631 (1961).PubMedGoogle Scholar
  74. Haigh, A.L., A.H. Kitchin, and M. Pickford: The effect of oxytocin on hand blood flow in man following the administration of an oestrogen and isoprenaline. J. Physiol. (Lond.) 169, 161 (1963).Google Scholar
  75. —, S. Lloyd, and M. Pickford: A relationship between adrenaline and the mode of action of oxytocin and oestrogen on vascular smooth muscle. J. Physiol. (Lond.) 178, 563 (1965).Google Scholar
  76. Heeg, E., u. K. Meng: Die Wirkung des Bradykinins, Angiotensins und Vasopressins auf Vorhof, Papillarmuskel und isoliert durchströmte Herzpräparate des Meerschweinchens. Arch, exp. Path. Pharmakol. 250, 35 (1965).Google Scholar
  77. Heimburger, L., S. Teramoto, and H.B. Shumacker Jr.: Effect of surgical pituitrin upon portal and hepatic circulation. Surgery 48, 706 (1960).PubMedGoogle Scholar
  78. Hendricks, C.H.: The hemodynamic of a uterine contraction. Amer. J. Obstet. Gynec. 76, 969 (1958).PubMedGoogle Scholar
  79. Hershey, S.G., V.D.B. Mazzia, B.M. Altura, and L. Gyure: Effects of vasopressors on the microcirculation and on survival in hemorrhagic shock. Anesthesiology 26, 179 (1965).PubMedGoogle Scholar
  80. Hertting, G., and J. Suko: Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and [3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Brit. J. Pharmacol. 26, 686 (1966).PubMedGoogle Scholar
  81. Hochuli, E.: Klinische Erfahrungen mit der lokalen Anwendung von Octapressin in der Gynäkologie und in der Geburtshilfe. Schweiz, med. Wschr. 92, 654 (1962).Google Scholar
  82. Holmes, S.W., E.W. Horton, and I.H.M. Main: The effect of prostaglandin E, on responses of smooth muscle to catechol amines, angiotensin and vasopressin. Brit. J. Pharmacol. 21, 538 (1963).PubMedGoogle Scholar
  83. Honoré, L. H.: The effects of single doses of deoxycorticosterone acetate (Doca) and cortisone on the vascular response of female rats to posterior pituitary hormones. Quart. J. exp. Physiol. 47, 334 (1962a).PubMedGoogle Scholar
  84. —: The vascular responses of male rats to post-pituitary hormones after treatment with deoxycorticosterone acetate (Doca) and cortisone. Quart. J. exp. Physiol. 47, 345 (1962b).PubMedGoogle Scholar
  85. —, and S. M. Lloyd: Posterior lobe hormones on the vascular response of the male rat after castration. J. Physiol. (Lond.) 155, 61 P (1961a).Google Scholar
  86. —: The effects of castration on the vascular responses of male rats to posterior pituitary hormones. J. Physiol. (Lond.) 159, 183 (1961b).Google Scholar
  87. Ichiyanagi, K., and L.E. Morris: Effect of cyclopropane and various oxytocics on cardiac rhythm in the parturient woman. Anesthesiology 20, 669 (1959).PubMedGoogle Scholar
  88. De Jong, W., and St. M. McLeod: Effect of autonomie blocking agents on the cardiovascular effects of Octapressin in the rat. Europ. J. Pharmacol. 1, 93 (1967).Google Scholar
  89. Karp, D., S.H. Rinzler, and J. Travell: Effects of ergometrine (ergonovine) on the isolated atherosclerotic heart of the cholesterol-fed rabbit. Brit. J. Pharmacol. 15, 333 (1960).PubMedGoogle Scholar
  90. Katz, D., D.J. Paulo, W.S. Rosenthal, and H. Weisbert: Selective therapy in bleeding esophageal varices. Gastroenterology 48, 826 (1965).Google Scholar
  91. Katz, L.N., and E. Lindner: The reaction of the coronary vessels to drugs and other substances. J. Amer. med. Ass. 113, 2116 (1939).Google Scholar
  92. Katz, R. L.: Antiarrhythmic action of synthetic oxytocin in anesthetized man. Experientia (Basel) 19, 160 (1963).Google Scholar
  93. —: Antiarrhythmic and cardiovascular effects of synthetic oxytocin. Anesthesiology 25, 653 (1964).PubMedGoogle Scholar
  94. —: Epinephrine and PLV2: cardiac rhythm and local vasoconstrictor effects. Anesthesiology 26, 619 (1965).PubMedGoogle Scholar
  95. —, R.P. Bircher, E.M. Papper, and S.O. Wang: Effects of synthetic oxytocin on cardiac arrhythmias. Scientific Exhibit, Amer. med. Ass., Atlantic City (N.J.), June 16-20, 1963.Google Scholar
  96. Kitrchin, A.H., H. Konzett, and M. Pickford: Comparison of effects of valyl3-oxytocin and Syntocinon in the cardiovascular system of man. Brit. J. Pharmacol. 14, 567 (1959).Google Scholar
  97. —, S. M. Lloyd, and M. Pickford: Some actions of oxytocin on the cardiovascular system in man. Clin. Sci. 18, 399 (1959).Google Scholar
  98. Klassen, G. A., J.W. Rubin, and M. McGregor: The effect of synthetic oxytocin on impaired atrioventricular conduction. Amer. J. Cardiol. 12, 523 (1963).PubMedGoogle Scholar
  99. Klingenström, P., and L. Westermark: Local tissue-oxygen tension after adrenaline, nor-adrenaline and Octapressin in local anaesthesia. Acta anaesth. scand. 8, 261 (1964).Google Scholar
  100. Kordik, P.: Responses of coronary vessels to pituitary (posterior lobe) extract and to adrenaline. Brit. J. Pharmacol. 6, 75 (1951).PubMedGoogle Scholar
  101. Kullander, S., and E. Wide: A synthetic vasopressin (Octapressin Sandoz) for haemostasis during cone biopsy of the cervix. Acta obstet, gynec. scand. 45, 102 (1966).Google Scholar
  102. Landesman, R., and B. Mendelsohn: The uterine omentum of the rat and its response to vasoconstrictor drugs. Amer. J. Obstet. Gynec. 72, 84 (1956).PubMedGoogle Scholar
  103. Lipton, B., S.G. Hershey, and S. Baez: Compatibility of oxytocics with anesthetic agents. J. Amer. med. Ass. 179, 410 (1962).Google Scholar
  104. Lloyd, S.: The vascular responses of the rat during the reproductive cycle. J. Physiol. (Lond.) 148, 625 (1959a).Google Scholar
  105. —: Changes in the vascular responses of the rat during pregnancy. J. Physiol. (Lond.) 149, 586 (1959b).Google Scholar
  106. —, and M. Pickford: The action of posterior pituitary hormones and oestrogens on the vascular system of the rat. J. Physiol. (Lond.) 155, 161 (1961a).Google Scholar
  107. —: Renal response to oxytocin and vasopressin in the presence of stilboestrol. J. Physiol. (Lond.) 158, 40 P (1961b).Google Scholar
  108. — The effect of oestrogens and sympathetic denervation on the response to oxytocin of the blood vessels in the hind limb of the dog. J. Physiol. (Lond.) 163, 362 (1962).Google Scholar
  109. Lloyd, S.M.: Mode of action of oxytocin on blood vessels. In: Oxytocin, vasopressin and their structural analogues, p. 37. Ed. by J. Rudinger. Oxford: Pergamon Press 1964.Google Scholar
  110. Lockett, M.F.: An action of oxytocin on the cardiovascular system. J. Physiol. (Lond.) 136, 26 P (1957).Google Scholar
  111. Longo, L.D., J.A. Morris, R. W. Smith, R. Beck, and N.S. Assali: Hemodynamic and renal effects of Octapressin. Proc. Soc. exp. Biol. (N.Y.) 115, 766 (1964).Google Scholar
  112. Louis, W. J., and A. E. Doyle: The relationship between the vascular responses to the peptides Angiotensin and Pitressin. Clin. Sci. 31, 255 (1966).PubMedGoogle Scholar
  113. Maxwell, G.M.: The cardiovascular effects of Octapressin. Arch. int. Pharmacodyn. 158, 17 (1965).PubMedGoogle Scholar
  114. Mayes, B.T., and R.P. Shearman: Experience with synthetic oxytocin. The effects on the cardiovascular system and its use for the induction of labour and control of the third stage. J. Obstet. Gynaec. Brit. Emp. 63, 812 (1956).PubMedGoogle Scholar
  115. Mazzia, V.D.B., J.M. McKenna, and L. Gyure: Influence of a synthetic analogue of vasopressin on the microcirculation and on survival in shock. Fed. Proc. 23, 539 (1964).Google Scholar
  116. McGee, J. E.: Effect of Syntocinon on blood pressure in the second and third stages of labor. Obstet, gynec. Surv. 16, 44 (1960).Google Scholar
  117. Mellander, S.: Comparative studies on the adrenergic neurohormonal control of resistance and capacitance blood vessels in the cat. Acta physiol. scand. 50, Suppl. 176, 1 (1960).Google Scholar
  118. Melville, K.I., and D.R. Varma: Synthetic oxytocin as an antagonist of experimental cardiac anoxic changes in rabbits. Brit. J. Pharmacol. 17, 218 (1961).PubMedGoogle Scholar
  119. Morris, L.E., M. J. Thornton, and J.W. Harris: Comparison of the effect of pituitrin, pito-cin, and ergonovine on cardiac rhythm during cyclopropane anesthesia for parturition. Amer. J. Obstet. Gynec. 63, 171 (1952).PubMedGoogle Scholar
  120. Munchow, O.B., and T. Kurze: Hemostatic effectiveness of infiltration with felypressin prior to skin incisions. J. Amer. med. Ass. 196, 625 (1966).Google Scholar
  121. Munsick, R.A.: Local hemostasis in gynecologic surgery. Rocky Mtn med. J. 63, 33 (1966).Google Scholar
  122. Nakano, J.: Cardiovascular effect of oxytocin in rodents and a marsupial. Proc. Soc. exp. Biol. (N.Y.) 115, 707 (1964).Google Scholar
  123. —, and R.D. Fisher: Studies on the cardiovascular effects of synthetic oxytocin. J. Pharmacol, exp. Ther. 142, 206 (1963).Google Scholar
  124. —, and J. S. Shackford: Effect of synthetic vasopressins on the myocardial contractile force in the isolated guinea-pig atria. Experientia (Basel) 21, 474 (1965).Google Scholar
  125. Nash, C. B.: Alteration of vasopressin tachyphylaxis by reserpine pretreatment. Arch. int. Pharmacodyn. 155, 90 (1965).PubMedGoogle Scholar
  126. —, L.D. Boyajy, and E.S. Manley: Vasopressin antagonism of adrenergic vasodilation. Arch. int. Pharmacodyn. 133, 433 (1961).PubMedGoogle Scholar
  127. Nashold Jr., B.S., E. Mannarino, and M. Wunderlich: Pressor-depressor blood pressure responses in the cat after intraventricular injection of drugs. Nature (Lond.) 193, 1297 (1962).Google Scholar
  128. Nelson, R.A., L.G. May, A. Bennett, M. Kobayashi, and R. Gregory: Comparison of the effects of pressor and depressor agents and influences on pulmonary and systemic pressures of normotensive and hypertensive subjects. Amer. Heart J. 50, 172 (1955).PubMedGoogle Scholar
  129. Orengo, F.: Anwendung eines synthetischen Vasopressinanalogon als Haemostatikum in der geburtshilflichen und gynäkologischen Chirurgie. Gynaecologia (Basel) 160, 221 (1965).Google Scholar
  130. Panisset, J. C., and A. Beaulnes: The effect of oxytocin on experimental cardiac arrhythmia. Rev. canad. Biol. 20, 47 (1961).PubMedGoogle Scholar
  131. Parsloe, C.P., L.E. Morris, and O.S. Orth: The relationship of various anesthetic agents to the action of pituitrin, pitressin and pitocin. Anesthesiology 11, 76 (1950).PubMedGoogle Scholar
  132. Paulet, G., J.P. Bernard, et R. Le Bars: Action de la vasopressine sur la masse sanguine pulmonaire chez le chien. C.R. Soc. Biol. (Paris) 159, 2485 (1965).Google Scholar
  133. Perroni, G., F. Bernava, F. S. Briguglio, e A. Bertolami: Studio di alcuni effetti dell’Octa-pressina sul sistema cardiovascolare nell’uomo. Minerva med. sicil. 10, 3 (1965).Google Scholar
  134. Phelan, E.L., I. Eryetishir, M. Dah, and F. H. Smirk: Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium. Circulat. Res. 10, 817 (1962).PubMedGoogle Scholar
  135. Pickford, M.: Effects of neurohypophysial hormones on the vascular system. In: Oxytocin, vasopressin and their structural analogues, p. 31. Ed. by J. Rudinger. Oxford: Pergamon Press 1964.Google Scholar
  136. —: Neurohypophysis and vascular reactions. In: The pituitary gland, vol. Ill, p. 399. Ed. by G.W. Harris and B.T. Donovan. London: Butterworths 1966.Google Scholar
  137. Poppy, J. H.: Pressor and emetic effects of oxytocics in the fourth stage of labor. Obstet, gynec. Surv. 22, 185 (1963).Google Scholar
  138. Potter, H.D., and D.C. Sutfin: Effects of vasopressin on femoral arterial blood flow and pressure in the anesthetized dog. Proc. Soc. exp. Biol. (N.Y.) 106, 511 (1961).Google Scholar
  139. Ribot, S., S. Abramowitz, H. Green, M. J. Small, and I. Schwartz: Cardiovascular effects of oxytocin and comparison with related polypeptides. Amer. J. med. Sci. 248, 61 (1964).PubMedGoogle Scholar
  140. —, W.S. Kelhoffer, H. Green, M.J. Small, and I. Schwartz: Cardiovascular effects of phenylalanyl-2-lysyl-8-vasopressin (PLV-2). Amer. J. med. Sci. 246, 479 (1963).PubMedGoogle Scholar
  141. — —, H. Green, M.J. Small, and S. Abramowitz: Cardiovascular effects of vasopressin. Amer. J. med. Sci. 242, 612 (1961).PubMedGoogle Scholar
  142. Rushmer, R.F., D.L. Franklin, R.L. Van Citters, and O.A. Smith: Changes in peripheral blood flow distribution in healthy dogs. Circulat. Res. 9, 675 (1961).PubMedGoogle Scholar
  143. Schmidt, L., W. Bernauer u. H. Menzel: Die Wirkung von Phenylalanin-2-Lysin-8-Vaso-pressin and Lysin-8-Vasopressin auf Coronardurchblutung und Blutdruck des Hundes und den Rattenuterus. Arzneimittel-Forsch. 12, 1019 (1962).Google Scholar
  144. Schofield, B.M., and J.M. Walker: Perfusion of the coronary arteries of the dog. J. Physiol. (Lond.) 122, 489 (1953).Google Scholar
  145. Schwartz, S.I., H.W. Bales, G.L. Emerson, and E.B. Mahoney: The use of intravenous pituitrin in treatment of bleeding esophageal varices. Surgery 45, 72 (1959).PubMedGoogle Scholar
  146. Segel, N., T. J. Bayley, A. Paton, P.W. Dykes, and J.M. Bishop: The effects of synthetic vasopressin and angiotensin on the circulation in cirrhosis of the liver. Clin. Sci. 25, 43 (1963).PubMedGoogle Scholar
  147. Seldinger, S.I., and R. Sundblad: Splenic regulation of portal flow in man. Scand. J. clin. Lab. Invest. 15, 380 (1963).PubMedGoogle Scholar
  148. Shaldon, ST., W. Dolle, L. Guevara, F.L. Iber, and S. Sherlock: Effect of pitressin on the splanchnic circulation in man. Circulation 24, 797 (1961).PubMedGoogle Scholar
  149. —, and S. Sherlock: The use of vasopressin (“Pitressin”) in the control of bleeding from oesophageal varices. Lancet 1960 II, 222.Google Scholar
  150. Shanks, C.A.: Intravenous Octapressin during halothane anaesthesia. A pilot study. Brit. J. Anaesth. 35, 640 (1963).Google Scholar
  151. Siener, H.: Vergleichende Untersuchungen über die uteruswirksamen und blutdrucksteigernden Eigenschaften von Syntocinon (Sandoz), Orasthin (Hoechst) und Oxystin (A.W.D.). Zbl. Gynäk. 80, 903 (1958).Google Scholar
  152. Slotnik, I.L., and J.D. Teigland: Cardiac accidents following vasopressin injection (Pitressin). J. Amer. med. Ass. 146, 1127 (1951).Google Scholar
  153. Somlyo, A.V., C.Y. Woo, and A. P. Somlyo: Responses of nerve-free vessels to vasoactive amines and polypeptides. Amer. J. Physiol. 208, 748 (1965).PubMedGoogle Scholar
  154. Stavraky, G.W., and R. J. Oliver: Influence of the posterior pituitary on the pressor action of epinephrine. Fed. Proc. 11, 392 (1952).Google Scholar
  155. Van Der Straeten, M., et I. Leusen: Influence de la pituitrine sur la circulation pulmonaire. Arch. int. Pharmacodyn. 96, 487 (1954).Google Scholar
  156. Supek, Z., B. Uroic u. V. Gjtjriš: Über den Mechanismus der verstärkenden Wirkung des Chlorpromazins auf die Blutdruckerhöhung durch Vasopressin. Arch. exp. Path. Pharma-kol. 238, 139 (1960).Google Scholar
  157. V. Gjtjriš —, and N. Marijan: The effect of adrenergic blocking agents and of chlorpromazine on blood pressure increase by vasopressin and angiotensin. J. Pharm. Pharmacol. 14, 284 (1962).PubMedGoogle Scholar
  158. Takács, L., and K. Albert: The effect of vasopressin on the circulation of the rat organs, with special consideration of the skin. Experientia (Basel) 19, 365 (1963).Google Scholar
  159. Texter, E.C., C.C. Chou, and H.C. Laureta: Local effects of Octapressin and vasopressin on segmental resistance of the mesenteric and portal circulations. Gastroenterology 48, 497 (1965).Google Scholar
  160. Texter Jr., E.C., C.C. Chou, St. L. Merrill, H.C. Laureta, and E.D. Fröhlich: Direct effects of vasoactive agents on segmental resistance of the mesenteric and portal circulation. J. Lab. clin. Med. 64, 624 (1964).PubMedGoogle Scholar
  161. Tsaktris, A., u. A. Bühlmann: Experimentelle Untersuchungen beim Menschen über die Wirkung von Vasopressin auf die Leberdurchblutung und den portalen Druck. Schweiz, med. Wschr. 92, 147 (1962).Google Scholar
  162. —: Kreislaufwirkungen eines neuen synthetischen Vasopressins. Experimentelle Untersuchungen mit (2-Phenylalanin-8-Lysin) Vasopressin. Dtsch. med. Wschr. 88, 46 (1963).Google Scholar
  163. —, U. P. Haemmerle, and A. Bühlmann: Reduction of portal venous pressure in cirrhotic patients with bleeding from oesophageal varices, by administration of a vasopressin derivative, phenylalanine2-lysine8-vasopressin. Amer. J. Med. 36, 825 (1964).Google Scholar
  164. Wagner, H.N., and E. Braunwald: The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. J. clin. Invest. 35, 1412 (1956).PubMedGoogle Scholar
  165. Wakim, K.G., C. Denton, and H.E. Essex: Certain cardiovascular effects of vasopressin (Pitressin). Amer. Heart J. 47, 77 (1954).PubMedGoogle Scholar
  166. Weidmann, H., u. A. Cerletti: Verstärkung des Blutdruckeffektes von Vasopressin durch Reserpin. Helv. physiol. pharmacol. Acta 19, C 119 (1961).Google Scholar
  167. Woodbury, R. A., and B.E. Abreu: Influence of oxytocin (Pitocin) upon the heart and blood pressure of the chicken, rabbit, cat, dog and turtle. Amer. J. Physiol. 142, 114 (1944).Google Scholar
  168. —, and R.P. Ahlquist: The cutaneous vasodilating action of Pitressin. J. Pharmacol, exp. Ther. 86, 14 (1946).Google Scholar
  169. —, W.F. Hamilton, P.P. Volpitto, B.E. Arbreu, and H.T. Harper: Cardiac and blood pressure effects of Pitocin (oxytocin) in man. J. Pharmacol, exp. Ther. 81, 95 (1944).Google Scholar
  170. Zweifach, B.W.: Peripheral circulatory changes as criteria for hemorrhagic shock therapy. Circulation 1, 433 (1950).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1968

Authors and Affiliations

  • K. Saameli

There are no affiliations available

Personalised recommendations